SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-004308
Filing Date
2018-05-08
Accepted
2018-05-08 16:16:58
Documents
52
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q zyne-20180331x10q.htm 10-Q 889882
2 EX-31.1 zyne-20180331ex311c84de0.htm EX-31.1 13595
3 EX-31.2 zyne-20180331ex31254e03d.htm EX-31.2 13367
4 EX-32.1 zyne-20180331ex321a534b1.htm EX-32.1 6151
5 EX-32.2 zyne-20180331ex322e39628.htm EX-32.2 6167
6 GRAPHIC zyne20180331x10q001.jpg GRAPHIC 92919
  Complete submission text file 0001558370-18-004308.txt   3903684

Data Files

Seq Description Document Type Size
7 EX-101.INS zyne-20180331.xml EX-101.INS 824720
8 EX-101.SCH zyne-20180331.xsd EX-101.SCH 26279
9 EX-101.CAL zyne-20180331_cal.xml EX-101.CAL 28844
10 EX-101.DEF zyne-20180331_def.xml EX-101.DEF 110693
11 EX-101.LAB zyne-20180331_lab.xml EX-101.LAB 243554
12 EX-101.PRE zyne-20180331_pre.xml EX-101.PRE 211396
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37526 | Film No.: 18814789
SIC: 2834 Pharmaceutical Preparations